Assignee
MEDIMMUNE LLC
US·186 granted patents·225 pending applications·2,372 citations·filing 2001–2025
Top patents by PatentIndex Score
411 records- 0199US7704497B2Molecules with extended half-lives, compositions and uses thereofMEDIMMUNE LLC·Filed 2007·Granted Apr 27, 2010·94 cites·49 claims
- 0299US7670600B2Molecules with extended half-lives, compositions and uses thereofMEDIMMUNE LLC·Filed 2006·Granted Mar 2, 2010·230 cites·26 claims
- 0399US7658921B2Molecules with extended half-lives, compositions and uses thereofMEDIMMUNE LLC·Filed 2007·Granted Feb 9, 2010·185 cites·14 claims
- 0498US8012476B2Molecules with extended half-lives, compositions and uses thereofMEDIMMUNE LLC·Filed 2010·Granted Sep 6, 2011·55 cites·28 claims
- 0598US7553489B2Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatmentMEDIMMUNE LLC·Filed 2006·Granted Jun 30, 2009·44 cites·18 claims
- 0697US8574593B2Influenza hemagglutinin and neuraminidase variantsMEDIMMUNE LLC·Filed 2012·Granted Nov 5, 2013·29 cites·20 claims
- 0797US8475792B2Molecules with extended half-lives, compositions and uses thereofMEDIMMUNE LLC·Filed 2012·Granted Jul 2, 2013·49 cites·20 claims
- 0897US8048430B2Influenza hemagglutinin and neuraminidase variantsMEDIMMUNE LLC·Filed 2010·Granted Nov 1, 2011·37 cites·24 claims
- 0997US7790655B2Cell display of antibody librariesMEDIMMUNE LLC·Filed 2006·Granted Sep 7, 2010·36 cites·15 claims
- 1097US7566458B2Influenza hemagglutinin and neuraminidase variantsMEDIMMUNE LLC·Filed 2004·Granted Jul 28, 2009·75 cites·38 claims
- 1197US7527800B2Influenza hemagglutinin and neuraminidase variantsMEDIMMUNE LLC·Filed 2005·Granted May 5, 2009·36 cites·29 claims
- 1296US8039002B2Influenza hemagglutinin and neuraminidase variantsMEDIMMUNE LLC·Filed 2007·Granted Oct 18, 2011·16 cites·29 claims
- 1396US7847082B2Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatmentMEDIMMUNE LLC·Filed 2009·Granted Dec 7, 2010·26 cites·33 claims
- 1496US7829086B2Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseMEDIMMUNE LLC·Filed 2007·Granted Nov 9, 2010·43 cites·24 claims
- 1596US7785592B2Stabilized liquid anti-RSV antibody formulationsMEDIMMUNE LLC·Filed 2007·Granted Aug 31, 2010·33 cites·82 claims
- 1696US7459162B2Influenza hemagglutinin and neuraminidase variantsMEDIMMUNE LLC·Filed 2006·Granted Dec 2, 2008·36 cites·18 claims
- 1795US11787853B2Neutralizing anti-influenza b antibodies and uses thereofMEDIMMUNE LLC·Filed 2021·Granted Oct 17, 2023·2 cites·26 claims
- 1895US10442854B2Neutralizing anti-influenza binding molecules and uses thereofMEDIMMUNE LLC·Filed 2016·Granted Oct 15, 2019·13 cites·11 claims
- 1995US9988459B2Anti-IFNAR1 antibodies with reduced Fc ligand affinityMEDIMMUNE LLC·Filed 2017·Granted Jun 5, 2018·21 cites·2 claims
- 2095US9574000B2Anti-human B7-H4 antibodies and their usesMEDIMMUNE LLC·Filed 2013·Granted Feb 21, 2017·62 cites·15 claims
- 2195US9527927B2Modified polypeptides for bispecific antibody scaffoldsMEDIMMUNE LLC·Filed 2012·Granted Dec 27, 2016·41 cites·11 claims
- 2295US8354114B2Multi plasmid system for the production of influenza virusMEDIMMUNE LLC·Filed 2006·Granted Jan 15, 2013·30 cites·9 claims
- 2395US7659374B2Eph receptor Fc variants with enhanced antibody dependent cell-mediated cytotoxicity activityMEDIMMUNE LLC·Filed 2005·Granted Feb 9, 2010·28 cites·14 claims
- 2495US7504109B2Influenza hemagglutinin and neuraminidase variantsMEDIMMUNE LLC·Filed 2005·Granted Mar 17, 2009·34 cites·16 claims
- 2594US11661449B2RSV-specific antibodies and functional parts thereofMEDIMMUNE LLC·Filed 2021·Granted May 30, 2023·2 cites·26 claims
- 2694US9738723B2Humanized anti-OX40 antibodies and uses thereofMEDIMMUNE LLC·Filed 2015·Granted Aug 22, 2017·20 cites·24 claims
- 2794US8007793B2Stabilized liquid anti-RSV antibody formulationsMEDIMMUNE LLC·Filed 2010·Granted Aug 30, 2011·21 cites·47 claims
- 2894US7700130B2Preservation of bioactive materials by spray dryingMEDIMMUNE LLC·Filed 2007·Granted Apr 20, 2010·13 cites·22 claims
- 2994US7700735B2High potency recombinant antibodies and method for producing themMEDIMMUNE LLC·Filed 2001·Granted Apr 20, 2010·57 cites·38 claims
- 3094US7635568B2Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatmentMEDIMMUNE LLC·Filed 2004·Granted Dec 22, 2009·39 cites·95 claims
- 3194US7531342B2Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequencesMEDIMMUNE LLC·Filed 2003·Granted May 12, 2009·39 cites·15 claims
- 3293US11186628B2RSV-specific antibodies and functional parts thereofMEDIMMUNE LLC·Filed 2020·Granted Nov 30, 2021·3 cites·11 claims
- 3393US11174304B2Neutralizing anti-influenza B antibodies and uses thereofMEDIMMUNE LLC·Filed 2019·Granted Nov 16, 2021·5 cites·22 claims
- 3493US10457732B2Bispecific binding proteins and uses thereofMEDIMMUNE LLC·Filed 2017·Granted Oct 29, 2019·10 cites·12 claims
- 3593US8795661B2Molecules with extended half-lives, compositions and uses thereofMEDIMMUNE LLC·Filed 2013·Granted Aug 5, 2014·16 cites·24 claims
- 3693US8012736B2Multi plasmid system for the production of influenza virusMEDIMMUNE LLC·Filed 2003·Granted Sep 6, 2011·41 cites·8 claims
- 3793US7744901B2Influenza hemagglutinin and neuraminidase variantsMEDIMMUNE LLC·Filed 2009·Granted Jun 29, 2010·15 cites·17 claims
- 3893US7465574B2Recombinant RSV virus expression systems and vaccinesMEDIMMUNE LLC·Filed 2005·Granted Dec 16, 2008·14 cites·8 claims
- 3993US7465456B2Multi plasmid system for the production of influenza virusMEDIMMUNE LLC·Filed 2005·Granted Dec 16, 2008·18 cites·10 claims
- 4092US10988546B2BCMA monoclonal antibody-drug conjugateMEDIMMUNE LLC·Filed 2018·Granted Apr 27, 2021·8 cites·14 claims
- 4192US10759849B2Methods of treating S. aureus-associated diseasesMEDIMMUNE LLC·Filed 2019·Granted Sep 1, 2020·6 cites·21 claims
- 4292US10744204B2Conjugated compounds comprising cysteine-engineered antibodiesMEDIMMUNE LLC·Filed 2015·Granted Aug 18, 2020·8 cites·15 claims
- 4392US10689437B2RSV-specific antibodies and functional parts thereofMEDIMMUNE LLC·Filed 2018·Granted Jun 23, 2020·6 cites·16 claims
- 4492USD878564SDrug delivery implementMEDIMMUNE LLC·Filed 2018·Granted Mar 17, 2020·36 cites·1 claims
- 4592US10519221B2Neutralizing anti-influenza B antibodies and uses thereofMEDIMMUNE LLC·Filed 2019·Granted Dec 31, 2019·8 cites·21 claims
- 4692US8883992B2Humanized anti-CD19 antibodiesMEDIMMUNE LLC·Filed 2012·Granted Nov 11, 2014·11 cites·9 claims
- 4792US8664363B2Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseMEDIMMUNE LLC·Filed 2013·Granted Mar 4, 2014·10 cites·9 claims
- 4892US7740851B2Ultra high affinity neutralizing antibodiesMEDIMMUNE LLC·Filed 2003·Granted Jun 22, 2010·35 cites·32 claims
- 4992US7691379B2Anti-IL-9 antibody formulationsMEDIMMUNE LLC·Filed 2005·Granted Apr 6, 2010·19 cites·81 claims
- 5092US7601356B2Methods and compositions for increasing replication capacity of an influenza virusMEDIMMUNE LLC·Filed 2007·Granted Oct 13, 2009·20 cites·20 claims
Showing the top 50 of 411 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when MEDIMMUNE LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →